Cancer Genetics Company Profile (NASDAQ:CGIX)

About Cancer Genetics

Cancer Genetics logoCancer Genetics, Inc. is engaged in the field of personalized medicine, enabling precision medicine in the field of oncology through its diagnostic products and services, and molecular markers. The Company develops, commercializes and provides molecular- and biomarker-based tests and services that enable physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment, and enable biopharmaceutical companies engaged in oncology trials to select candidate populations and manage adverse drug reactions by providing information regarding genomic factors influencing subject responses to therapeutics. It has a range of disease-focused oncology testing portfolio. Its molecular- and biomarker-based diagnostic services are provided for three sectors: cancer centers and hospitals, biotechnology and biopharmaceutical companies, and the research community.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CGIX
  • CUSIP:
Key Metrics:
  • Previous Close: $2.45
  • 50 Day Moving Average: $2.12
  • 200 Day Moving Average: $1.81
  • 52-Week Range: $18,887,000.00 - $1.10
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.54
  • P/E Growth: -0.06
  • Market Cap: $46.27M
  • Outstanding Shares: 18,887,000
  • Beta: 1.44
Profitability:
  • Net Margins: -74.07%
  • Return on Equity: -63.26%
  • Return on Assets: -40.91%
Debt:
  • Debt-to-Equity Ratio: 0.12%
  • Current Ratio: 2.50%
  • Quick Ratio: 2.50%
Additional Links:
Companies Related to Cancer Genetics:

Analyst Ratings

Consensus Ratings for Cancer Genetics (NASDAQ:CGIX) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $9.00 (267.35% upside)

Analysts' Ratings History for Cancer Genetics (NASDAQ:CGIX)
Show:
DateFirmActionRatingPrice TargetDetails
9/27/2016HC WainwrightInitiated CoverageBuy$6.00View Rating Details
9/26/2016Rodman & RenshawInitiated CoverageBuy$6.00View Rating Details
3/15/2016AegisBoost Price TargetBuy$8.00 -> $15.00View Rating Details
3/11/2016Janney Montgomery ScottReiterated RatingBuy -> NeutralView Rating Details
5/14/2015Cantor FitzgeraldReiterated RatingBuy$13.00View Rating Details
(Data available from 2/27/2015 forward)

Earnings

Earnings History for Cancer Genetics (NASDAQ:CGIX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/8/2017        
11/10/2016Q316($0.28)($0.23)$6.93 million$6.80 millionViewN/AView Earnings Details
5/10/2016Q1($0.43)($0.39)$6.95 million$6.10 millionViewListenView Earnings Details
3/10/2016Q415($0.46)($0.48)$7.00 million$5.50 millionViewListenView Earnings Details
11/10/2015Q315($0.49)($0.56)$5.13 million$4.00 millionViewListenView Earnings Details
8/11/2015Q215($0.50)($0.51)$4.67 million$4.20 millionViewListenView Earnings Details
5/12/2015Q115($0.54)($0.44)$3.91 million$4.40 millionViewListenView Earnings Details
3/12/2015Q414($0.50)($0.49)$3.70 million$4.00 millionViewN/AView Earnings Details
11/10/2014($0.51)($0.41)ViewN/AView Earnings Details
8/14/2014Q214($0.37)($0.50)$2.13 million$3.20 millionViewN/AView Earnings Details
5/15/2014Q114($0.29)($0.27)$2.17 million$1.40 millionViewN/AView Earnings Details
3/26/2014Q4 13($0.36)($0.37)$1.95 million$1.90 millionViewN/AView Earnings Details
11/13/2013Q313($0.71)($0.61)$1.60 million$1.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cancer Genetics (NASDAQ:CGIX)
Current Year EPS Consensus Estimate: $-1.10 EPS
Next Year EPS Consensus Estimate: $-0.54 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.38)($0.28)($0.33)
Q2 20161($0.33)($0.33)($0.33)
Q3 20161($0.29)($0.29)($0.29)
Q4 20161($0.20)($0.20)($0.20)
Q1 20171($0.18)($0.18)($0.18)
Q2 20171($0.15)($0.15)($0.15)
Q3 20171($0.12)($0.12)($0.12)
Q4 20171($0.05)($0.05)($0.05)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cancer Genetics (NASDAQ:CGIX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cancer Genetics (NASDAQ:CGIX)
Insider Ownership Percentage: 25.40%
Institutional Ownership Percentage: 12.60%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/14/2016Geoffrey E HarrisDirectorBuy2,500$1.50$3,750.00View SEC Filing  
11/28/2016John PappajohnDirectorBuy100,000$1.45$145,000.00View SEC Filing  
11/16/2016Edward J SitarCFOSell3,333$1.56$5,199.48View SEC Filing  
11/14/2016John PappajohnDirectorBuy31,100$1.48$46,028.00View SEC Filing  
8/16/2016John PappajohnDirectorBuy45,000$2.29$103,050.00View SEC Filing  
8/15/2016John PappajohnDirectorBuy147,500$2.16$318,600.00View SEC Filing  
3/17/2016John PappajohnDirectorBuy50,000$2.64$132,000.00View SEC Filing  
3/17/2016Panna SharmaCEOBuy1,500$2.59$3,885.00View SEC Filing  
3/16/2016John PappajohnDirectorBuy100,000$2.53$253,000.00View SEC Filing  
3/15/2016Panna SharmaCEOBuy1,000$2.56$2,560.00View SEC Filing  
8/27/2015John PappajohnDirectorBuy5,000$9.61$48,050.00View SEC Filing  
6/25/2015Raju S.K. ChagantiDirectorSell5,296$12.00$63,552.00View SEC Filing  
6/12/2015Raju S.K. ChagantiDirectorSell7,000$12.01$84,070.00View SEC Filing  
6/11/2015Raju S.K. ChagantiDirectorSell46,454$12.03$558,841.62View SEC Filing  
6/8/2015Raju S.K. ChagantiDirectorSell24,583$12.03$295,733.49View SEC Filing  
5/14/2015John PappajohnDirectorBuy5,000$10.74$53,700.00View SEC Filing  
3/17/2015John PappajohnDirectorBuy50,000$7.36$368,000.00View SEC Filing  
3/16/2015Edward J SitarCFOBuy1,000$6.99$6,990.00View SEC Filing  
12/16/2014John PappajohnDirectorBuy5,589$6.20$34,651.80View SEC Filing  
12/15/2014John PappajohnDirectorBuy3,634$6.14$22,312.76View SEC Filing  
12/11/2014John PappajohnDirectorBuy27,087$6.03$163,334.61View SEC Filing  
12/10/2014John PappajohnDirectorBuy5,773$5.96$34,407.08View SEC Filing  
12/9/2014John PappajohnDirectorBuy39,686$5.35$212,320.10View SEC Filing  
5/21/2014Edward SitarCFOBuy1,000$10.67$10,670.00View SEC Filing  
5/21/2014John PappajohnDirectorBuy50,000$10.31$515,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cancer Genetics (NASDAQ:CGIX)
DateHeadline
nasdaq.com logoCancer Genetics India Partners with CSIR-Centre for Cellular and ... - Nasdaq (NASDAQ:CGIX)
www.nasdaq.com - February 24 at 4:25 PM
News IconStock Levels in Focus for Cancer Genetics Inc (CGIX) - The Standard (NASDAQ:CGIX)
6milestandard.com - February 24 at 4:25 PM
finance.yahoo.com logoCancer Genetics India Partners with CSIR-Centre for Cellular and Molecular Biology to Organize the 2nd Annual Next Generation Sequencing Conference in India (NASDAQ:CGIX)
finance.yahoo.com - February 23 at 4:13 PM
marketexclusive.com logoCANCER GENETICS, INC. (NASDAQ:CGIX) Files An 8-K Other Events - Market Exclusive (NASDAQ:CGIX)
marketexclusive.com - February 23 at 2:24 AM
News IconCancer Genetics Inc CGIX Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NASDAQ:CGIX)
www.bioportfolio.com - February 22 at 12:09 PM
finance.yahoo.com logoCancer Genetics, Inc. to Receive $1.0 Million in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program (NASDAQ:CGIX)
finance.yahoo.com - February 22 at 12:09 PM
biz.yahoo.com logoCANCER GENETICS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:CGIX)
biz.yahoo.com - February 22 at 12:09 PM
News IconMarket Spotlight: Focusing on Shares of Cancer Genetics, Inc. (NASDAQ:CGIX) - Midway Monitor (NASDAQ:CGIX)
midwaymonitor.com - February 21 at 2:52 PM
News IconCancer Genetics, Inc. Hereditary Breast & Ovarian Cancer Panel Selected By Global Biopharma To Power 1000+ ... - Clinical Leader (NASDAQ:CGIX)
www.clinicalleader.com - February 17 at 5:56 PM
News IconThe Charts For Cancer Genetics, Inc. (CGIX) Is Speaking Volumes Today - NY Stock News (NASDAQ:CGIX)
nystocknews.com - February 17 at 5:56 PM
marketexclusive.com logoCANCER GENETICS, INC. (NASDAQ:CGIX) Files An 8-K Departure of Directors or Certain Officers; Election of ... - Market Exclusive (NASDAQ:CGIX)
marketexclusive.com - February 17 at 5:56 PM
biz.yahoo.com logoCANCER GENETICS, INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CGIX)
biz.yahoo.com - February 16 at 9:21 PM
biz.yahoo.com logoCANCER GENETICS, INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CGIX)
biz.yahoo.com - February 16 at 9:21 PM
biz.yahoo.com logoCANCER GENETICS, INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CGIX)
biz.yahoo.com - February 16 at 9:21 PM
News IconUnusual Volume Spotted in Cancer Genetics, Inc. (NASDAQ:CGIX) Stock - Winfield Review (NASDAQ:CGIX)
winfieldreview.com - February 16 at 4:20 PM
realistinvestor.com logoCancer Genetics, Inc. (NASDAQ:CGIX) Mean Rating At $1 - RealistInvestor.com (NASDAQ:CGIX)
www.realistinvestor.com - February 16 at 4:20 PM
finance.yahoo.com logoCancer Genetics, Inc. Hereditary Breast & Ovarian Cancer Panel Selected by Global Biopharma to Power 1,000+ Patient Clinical Study (NASDAQ:CGIX)
finance.yahoo.com - February 16 at 9:30 AM
globenewswire.com logoCancer Genetics, Inc. to Present at the 2nd Annual Disruptive Growth & Healthcare Conference - GlobeNewswire (press release) (NASDAQ:CGIX)
globenewswire.com - February 14 at 10:00 PM
finance.yahoo.com logoCancer Genetics, Inc. to Present at the 2nd Annual Disruptive Growth & Healthcare Conference (NASDAQ:CGIX)
finance.yahoo.com - February 13 at 4:53 PM
News IconCan This Stock Keep on Trucking? Lofty Projections For Cancer Genetics, Inc. (NASDAQ:CGIX) - Aiken Advocate (NASDAQ:CGIX)
aikenadvocate.com - February 7 at 5:21 PM
News IconInvestor Focus on Shares of Cancer Genetics Inc (CGIX) - Rives Journal (NASDAQ:CGIX)
rivesjournal.com - February 7 at 5:21 PM
openpr.com logo2016 Cancer Genetics Inc (CGIX) Industry Analysis Report (NASDAQ:CGIX)
www.openpr.com - February 3 at 4:31 PM
News IconExplore Cancer Genetics Inc (CGIX) - product pipeline analysis, 2016 update (NASDAQ:CGIX)
www.whatech.com - February 2 at 4:31 PM
News IconSADIF Analytics releases new summary due diligence report for Cancer Genetics Inc ($CGIX). (NASDAQ:CGIX)
reports.pr-inside.com - February 2 at 2:33 AM
News IconTechnical Study: Following Indicators for Cancer Genetics Inc (CGIX) - Sherwood Daily (NASDAQ:CGIX)
sherwooddaily.com - February 1 at 9:31 PM
News IconInvestors Keen on a Bargain are Looking at Cancer Genetics, Inc. (NASDAQ:CGIX) - Prospect Journal (NASDAQ:CGIX)
prospectjournal.com - February 1 at 9:31 PM
News IconIncrease in Volatility Draws Attention to Shares of Cancer Genetics, Inc. (NASDAQ:CGIX) - Wall Street Beacon (NASDAQ:CGIX)
wsbeacon.com - February 1 at 9:31 PM
News IconTechnical Investor Update on Shares of Cancer Genetics Inc (CGIX) - Sherwood Daily (NASDAQ:CGIX)
sherwooddaily.com - February 1 at 6:39 AM
News IconRelative Strength Index Review on Shares of Cancer Genetics Inc (CGIX) - Sherwood Daily (NASDAQ:CGIX)
sherwooddaily.com - January 30 at 5:03 PM
News IconChecking in on Signals for Cancer Genetics Inc (CGIX) - Sherwood Daily (NASDAQ:CGIX)
sherwooddaily.com - January 28 at 3:46 AM
realistinvestor.com logoMean Rating Of Cancer Genetics, Inc. (NASDAQ:CGIX) At $1 - RealistInvestor.com (NASDAQ:CGIX)
www.realistinvestor.com - January 26 at 10:11 PM
News IconInvestor Corner: Checking in on Shares of Cancer Genetics Inc (CGIX) - Sherwood Daily (NASDAQ:CGIX)
sherwooddaily.com - January 26 at 5:10 PM
News IconStock Seesawing as Volatility Sweeps in on Cancer Genetics, Inc. (NASDAQ:CGIX) - Wall Street Beacon (NASDAQ:CGIX)
wsbeacon.com - January 26 at 5:10 PM
News IconEnlivened Volatility Spotted in Shares of Cancer Genetics, Inc. (NASDAQ:CGIX) - Wall Street Beacon (NASDAQ:CGIX)
wsbeacon.com - January 26 at 2:36 AM
finance.yahoo.com logo12:49 pm Cancer Genetics launched a focused genomic panel for hereditary breast and ovarian cancer syndrome (NASDAQ:CGIX)
finance.yahoo.com - January 25 at 4:33 PM
finance.yahoo.com logoCancer Genetics, Inc. Launches Entry into Comprehensive Hereditary Cancer Testing for Breast & Ovarian Cancers, Addressing a $2.5 Billion Market (NASDAQ:CGIX)
finance.yahoo.com - January 25 at 4:33 PM
News IconGrowth Story Unfolding for Cancer Genetics, Inc. (NASDAQ:CGIX) - Prospect Journal (NASDAQ:CGIX)
prospectjournal.com - January 24 at 2:35 AM
News IconIs the Needle Ready to Move on Cancer Genetics, Inc. (NASDAQ ... - Prospect Journal (NASDAQ:CGIX)
prospectjournal.com - January 24 at 2:35 AM
News IconAre Insiders Filling Their Own Pockets With Shares? Insider Update on Cancer Genetics, Inc. (NASDAQ:CGIX) - Wall Street Beacon (NASDAQ:CGIX)
wsbeacon.com - January 23 at 4:32 PM
News IconLooking at Moving Averages for Cancer Genetics Inc (CGIX) - Sherwood Daily (NASDAQ:CGIX)
sherwooddaily.com - January 23 at 4:32 PM
News IconIndicator Level Review for Cancer Genetics Inc (CGIX) - Sherwood Daily (NASDAQ:CGIX)
sherwooddaily.com - January 20 at 3:32 AM
News IconAmplified Volatility Spotted in Shares of Cancer Genetics, Inc. (NASDAQ:CGIX) - Wall Street Beacon (NASDAQ:CGIX)
wsbeacon.com - January 20 at 3:32 AM
News IconFollowing the Charts on Shares of Cancer Genetics Inc (CGIX) - Sherwood Daily (NASDAQ:CGIX)
sherwooddaily.com - January 18 at 9:34 PM
News IconShooting From the Hip, Stock Reaches Most Volatile List: Cancer Genetics, Inc. (NASDAQ:CGIX) - Wall Street Beacon (NASDAQ:CGIX)
wsbeacon.com - January 18 at 9:34 PM
finance.yahoo.com logoTeladoc Announces Stock Sale to Finance Growing Business (NASDAQ:CGIX)
finance.yahoo.com - January 18 at 4:33 PM
News IconCancer Genetics & Lantern Pharma Announce Strategic Collaboration For Multiple Lead Oncology Compounds (NASDAQ:CGIX)
www.clinicalleader.com - January 18 at 3:07 AM
News IconTracking Corporate Insiders: What Are They Doing With Cancer Genetics, Inc. (NASDAQ:CGIX) - Wall Street Beacon (NASDAQ:CGIX)
wsbeacon.com - January 17 at 10:05 PM
News IconInvestors Priming the Pump as Stock Reaches Most Volatile List: Cancer Genetics, Inc. (NASDAQ:CGIX) - Wall Street Beacon (NASDAQ:CGIX)
wsbeacon.com - January 17 at 10:05 PM
News IconInvestors Swarm in on Cancer Genetics, Inc. (NASDAQ:CGIX) - Prospect Journal (NASDAQ:CGIX)
prospectjournal.com - January 17 at 10:05 PM
streetinsider.com logoCancer Genetics (CGIX), Lantern Pharma Announce Strategic ... - StreetInsider.com (NASDAQ:CGIX)
www.streetinsider.com - January 17 at 10:05 PM

Social

What is Cancer Genetics' stock symbol?

Cancer Genetics trades on the NASDAQ under the ticker symbol "CGIX."

Where is Cancer Genetics' stock going? Where will Cancer Genetics' stock price be in 2017?

4 equities research analysts have issued 12 month price targets for Cancer Genetics' stock. Their predictions range from $6.00 to $15.00. On average, they anticipate Cancer Genetics' stock price to reach $9.00 in the next year.

When will Cancer Genetics announce their earnings?

Cancer Genetics is scheduled to release their next quarterly earnings announcement on Wednesday, March, 8th 2017.

Who owns Cancer Genetics stock?

Cancer Genetics' stock is owned by a number of of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (1.64%). Company insiders that own Cancer Genetics stock include Edward J Sitar, Geoffrey E Harris, John Pappajohn, Panna Sharma and Raju SK Chaganti.

Who bought Cancer Genetics stock? Who is buying Cancer Genetics stock?

Cancer Genetics' stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. Company insiders that have bought Cancer Genetics stock in the last two years include Edward J Sitar, Geoffrey E Harris, John Pappajohn and Panna Sharma.

How do I buy Cancer Genetics stock?

Shares of Cancer Genetics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Cancer Genetics stock cost?

One share of Cancer Genetics stock can currently be purchased for approximately $2.45.

Cancer Genetics (NASDAQ:CGIX) Chart for Monday, February, 27, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Cancer Genetics (NASDAQ:CGIX)

Earnings History Chart

Earnings by Quarter for Cancer Genetics (NASDAQ:CGIX)

Dividend History Chart

Dividend Payments by Quarter for Cancer Genetics (NASDAQ:CGIX)

Last Updated on 2/27/2017 by MarketBeat.com Staff